These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 17192909
1. Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation. Nebbia G, Mattes FM, Cholongitas E, Garcia-Diaz A, Samonakis DN, Burroughs AK, Emery VC. Liver Transpl; 2007 Jan; 13(1):130-5. PubMed ID: 17192909 [Abstract] [Full Text] [Related]
2. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581 [Abstract] [Full Text] [Related]
3. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR, PV16000 Study Group. Liver Transpl; 2007 Oct; 13(10):1422-7. PubMed ID: 17902128 [Abstract] [Full Text] [Related]
4. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH. Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744 [Abstract] [Full Text] [Related]
5. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D, Posner MP, Fisher RA. Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360 [Abstract] [Full Text] [Related]
8. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. Clin Infect Dis; 2002 Oct 15; 35(8):974-81. PubMed ID: 12355385 [Abstract] [Full Text] [Related]
14. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Charlton M, Ruppert K, Belle SH, Bass N, Schafer D, Wiesner RH, Detre K, Wei Y, Everhart J. Liver Transpl; 2004 Sep 15; 10(9):1120-30. PubMed ID: 15350002 [Abstract] [Full Text] [Related]
15. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Clin Infect Dis; 2007 May 15; 44(10):1315-20. PubMed ID: 17443468 [Abstract] [Full Text] [Related]
16. Virology and pathogenesis of hepatitis C virus recurrence. Ramírez S, Pérez-Del-Pulgar S, Forns X. Liver Transpl; 2008 Oct 15; 14 Suppl 2():S27-35. PubMed ID: 18825723 [Abstract] [Full Text] [Related]
17. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J, Meng XQ, Yang MF, Zhou L, Chen XM, Hu MJ, Fan WW, Ma WH, Li LJ. Hepatobiliary Pancreat Dis Int; 2006 Feb 15; 5(1):34-8. PubMed ID: 16481279 [Abstract] [Full Text] [Related]